Tuesday, May 24, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Health | Novel Drug Form May Help Treat Calcium Related Disorders

Novel drug form may help treat calcium-related disorders

By IANS
Published: Published Date - 04:55 PM, Wed - 6 January 21
Representational Image "The technology can help make these calcitonin drugs safer and more effective," said Elizabeth Topp, Professor, Purdue University in the US.

New York: Researchers have found that a novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients.

For the study, published in the journal Biophysical Journal, a team of researchers developed a stabilized form of human calcitonin, which is a peptide drug already used for people with osteoporosis.

“The technology can help make these calcitonin drugs safer and more effective,” said Elizabeth Topp, Professor, Purdue University in the US.

The team created a prodrug form of the peptide hormone to increase its effectiveness as an osteoporosis treatment.

In humans, calcitonin is the hormone responsible for normal calcium homeostasis. When prescribed to osteoporosis patients, calcitonin inhibits bone resorption, resulting in increased bone mass.

Unfortunately, human calcitonin undergoes fibrillation in aqueous solution, leading to reduced efficacy when used as a therapeutic. As a substitute, osteoporosis patients are prescribed salmon calcitonin. It does not fibrillate as rapidly but suffers from low potency and the potential for several adverse side effects.

“Our approach will increase the therapeutic potential of human calcitonin, promising a more effective option to replace salmon calcitonin for osteoporosis and related disorders,” Topp added.

To decrease the fibrillation propensity and increase the therapeutic benefit of human calcitonin, Purdue researchers phosphorylated specific amino acid residues.

“This technology provides a way to stabilize them in a reversible way so that the stabilizing modification comes off when the drug is given to the patient,” Topp said.

  • Follow Us :
  • Tags
  • Corona Virus Deaths
  • Coronavirus
  • Coronavirus in India
  • Coronavirus Latest Updates

Related News

  • Q&A session on steps to achieve success amid competition in TT, NT’s awareness programme

  • TT, NT’s awareness programme in Hanamkonda gets good response

  • Telangana buys 30 lakh tonne paddy so far

  • Sadhguru hails Telangana’s efforts to improve farm sector

  • Malnutrition: Telangana’s efforts find place in UN report

  • Hyderabad: ISB students under scanner ahead of PM’s visit, alleges CPI leader

Latest News

  • Opinion: The new cold war will be fiercer

    3 hours ago
  • Editorial: Opening doors for regional cooperation

    4 hours ago
  • Cyber fraudsters swindle Rs 2.7 crore using ‘investment bait’ in Cyberabad

    4 hours ago
  • IPL 2022: Gujarat Titans qualify for final with seven-wicket win over RR

    4 hours ago
  • Nutreat offers healthy, nutritious food using traditional techniques

    4 hours ago
  • Telangana’s Lavanya makes it to Indian team for U-20 Asian Volleyball Championship

    5 hours ago
  • Think positive, improve skills experts tell aspirants in TT, NT’s awareness programme

    5 hours ago
  • Hyderabad: Swimming pool in Ameerpet reopens after two years

    5 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam